The unc-58 gene encodes a two-pore domain potassium channel (K2P) critical for maintaining neuronal and muscle cell excitability by regulating resting membrane potential . Key features:
Gain-of-function (GOF) mutation (unc-58(e665)): Causes hypercontraction and immobility due to altered ion selectivity (K⁺ to Na⁺) .
Loss-of-function (LOF) mutation: Results in subtle motility defects, including reduced thrashing rates in liquid .
unc-58 is widely used as a co-CRISPR marker due to its easily observable GOF phenotype . Notable findings from recent studies:
| Mutation Type | Phenotype | Functional Impact |
|---|---|---|
| GOF (e665) | Immobile, hypercontracted | Altered ion selectivity (Na⁺ influx) |
| LOF (qa3788) | Reduced thrashing in liquid | Disrupted K⁺ channel function |
| Null (bln223) | Similar to LOF CRISPR mutant | Complete loss of channel activity |
CRISPR-mediated mutations in unc-58 (e.g., qa3788) produce a 2nt deletion and 15nt insertion, leading to a premature stop codon and truncated protein lacking the C-terminal domain critical for channel gating .
While the search results describe monoclonal antibody development for other C. elegans proteins (e.g., UNC-10, PAS-7, ORC-2) , no antibodies targeting UNC-58 are documented. Key antibody development strategies include:
Immunization: Use of His-tagged fusion proteins for antigen generation .
Validation: Western blotting and whole-mount immunostaining to confirm specificity .
The absence of an "unc-58 Antibody" in published literature suggests:
Technical Challenges: K2P channels like UNC-58 may have low antigenicity due to transmembrane domain complexity.
Functional Redundancy: LOF phenotypes are subtle, reducing demand for antibodies in behavioral studies .
Prioritization: Antibody efforts focus on proteins with clearer phenotypic roles (e.g., synaptic vesicle markers like SNB-1) .
Researchers requiring UNC-58 detection might explore alternative methods such as CRISPR-tagging or transcriptomic approaches until antibodies become available.